Enabling Complexity: Drug Substance Manufacturing Via Continuous Flow

Continuous flow technology has become a cornerstone of modern pharmaceutical manufacturing. As drug substance molecular complexity continues to increase, flow chemistry is becoming an essential enabling technology. This webinar explores how flow chemistry facilitates the integration of complex synthetic methods, previously confined to research laboratories, into clinical and commercial production of Active Pharmaceutical Ingredients (APIs).

Dr. Matthew Bio, Chief Scientific Officer at Cambrex, showcases the application of flow technology for scaling up modern synthetic approaches from pilot-scale to commercial production. Specific examples will delve into the development and implementation of flow processes for cryogenic organometallic reactions and photochemistry. Additionally, Dr. Bio discusses the value of data-rich experimentation in accelerating development timelines and achieving first-time-right manufacturing.

View the webinar below to explore the relevance of continuous flow technology in pharmaceutical manufacturing as well as use cases to support the utilization of continuous flow throughout drug development.